IMC Chicago’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.26M Sell
274,700
-74,900
-21% -$2.19M ﹤0.01% 1513
2025
Q4
$10.1M Buy
349,600
+142,800
+69% +$4.29M ﹤0.01% 1216
2025
Q3
$5.74M Sell
206,800
-21,200
-9% -$536K ﹤0.01% 1476
2025
Q2
$5.55M Sell
228,000
-3,500
-2% -$76.7K ﹤0.01% 1327
2025
Q1
$4.81M Sell
231,500
-175,500
-43% -$4.41M ﹤0.01% 1245
2024
Q4
$9.58M Buy
407,000
+92,700
+29% +$2.28M ﹤0.01% 924
2024
Q3
$8.05M Sell
314,300
-135,300
-30% -$3.45M ﹤0.01% 917
2024
Q2
$10.6M Buy
449,600
+296,100
+193% +$7.47M 0.01% 765
2024
Q1
$4.41M Sell
153,500
-41,800
-21% -$1.26M ﹤0.01% 1011
2023
Q4
$6.41M Buy
195,300
+67,600
+53% +$1.84M ﹤0.01% 804
2023
Q3
$3.56M Buy
127,700
+50,900
+66% +$1.66M ﹤0.01% 825
2023
Q2
$2.62M Sell
76,800
-12,300
-14% -$387K ﹤0.01% 809
2023
Q1
$2.68M Sell
89,100
-57,300
-39% -$1.78M ﹤0.01% 776
2022
Q4
$4.13M Sell
146,400
-10,800
-7% -$343K 0.01% 653
2022
Q3
$5.17M Sell
157,200
-52,400
-25% -$1.92M 0.01% 558
2022
Q2
$6.6M Buy
209,600
+41,400
+25% +$1.45M 0.01% 509
2022
Q1
$7.72M Sell
168,200
-19,100
-10% -$911K 0.01% 505
2021
Q4
$11.5M Buy
187,300
+18,100
+11% +$1.25M 0.01% 467
2021
Q3
$12.6M Buy
169,200
+22,100
+15% +$1.85M 0.01% 449
2021
Q2
$13.6M Sell
147,100
-6,700
-4% -$570K 0.02% 398
2021
Q1
$13.6M Buy
+153,800
New +$15.3M 0.02% 379

Other funds holding ARKG

IMC Chicago's ARKG Position: Q4 2025 in Review

IMC Chicago sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 31,004 shares — an estimated $931K sold.

IMC Chicago first reported a position in ARKG in Q1 2021 and held it in 8 quarters. The position peaked at $1.96M in Q2 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • IMC Chicago reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 31,004 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $931K.
  • IMC Chicago first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 8 quarters.
  • IMC Chicago's ARK Genomic Revolution ETF position peaked at $1.96M in Q2 2025.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.